H.R. 7180, the Countering Captagon and Narcotics Post-Assad Act, modifies an existing federal strategy to address drug production and trafficking in the Middle East in the aftermath of Syria's political change. The bill expands the scope of an earlier law to focus on the production and trafficking of Captagon, methamphetamine, and other amphetamine-type stimulants throughout the region—particularly in Iraq—rather than just drugs linked to Syria's former Assad regime. The legislation requires the Department of Defense and other relevant agencies to develop an unclassified strategy assessing which countries are major sources or transit points for these drugs, evaluating local counter-narcotics capabilities, reviewing current U.S. assistance programs, and recommending ways to disrupt trafficking networks connected to former Syrian officials, Hezbollah, and Iran-backed groups. Though the bill does not specify new funding amounts or implementation timelines in the provided text, it directs the federal government to take coordinated military and law enforcement action to address what lawmakers characterize as a growing threat to regional stability and U.S. interests.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.